Document: Spatial and temporal organization of cellular signaling pathways heavily relies on compartmentalization. Structural surfaces for signal transduction can be formed by membranes, components of the cytoskeleton, membrane-surrounded organelles, or membrane-less organelles (MLOs). These MLOs occur in the cytoplasm and nucleoplasm of eukaryotic cells and have recently also been discovered in bacteria (Uversky, 2017; Brangwynne, 2013; Al-Husini et al., 2018) . These liquid-like subcellular compartments are believed to be formed by phase separation (Boeynaems et al., 2018) , a process that involves the spontaneous separation of a supersaturated solution into a dense and a dilute phase. The liquid-like nature of MLOs allows fusion and fission events and a dynamic exchange of components. MLOs comprise a variety of subcompartments including nucleoli, promyelocytic leukemia (PML) nuclear bodies, P bodies, and stress granules (SGs) (Boeynaems et al., 2018; Darling et al., 2018; Wheeler and Hyman, 2018) . The dense phase inside MLOs contains a high concentration of proteins, which may facilitate biochemical reactions and control signaling thresholds from these very crowded environments (Boeynaems et al., 2018; Gomes and Shorter, 2018; Woodruff et al., 2017) . In addition, MLOs can act as dynamic buffers for RNAs and proteins. This buffering function also serves as a passive noise filter and thus reduces the inherent randomness of chemical reactions (Saunders et al., 2012) . Different MLOs have a variety of functions ranging from the expression of rRNAs and pre-assembly of ribosomes (nucleoli) to the organization of the spindle apparatus (centrosomes) and mRNA splicing (splicing speckles) (Bernardi and Pandolfi, 2007; Boulon et al., 2010; Brangwynne, 2013; Hyman et al., 2014) . Aberrant forms of MLOs occur upon failure of the protein quality control system or by mutation of MLO-resident proteins, often causing age-related diseases such as amyotrophic lateral sclerosis, inclusion body myopathy, and frontotemporal dementia (Hock and Polymenidou, 2016; Malinovska et al., 2013; Ramaswami et al., 2013; Taylor et al., 2016) . Furthermore, various viruses hijack MLO proteins to aid in their replication (Dhillon and Rao, 2018; Mö ller and Schmitz, 2003; Nakagawa et al., 2018; Reineke and Lloyd, 2013) . MLOs are dynamically formed by an interplay between RNA and intrinsically disordered proteins (IDPs) that typically harbor low-sequence-complexity domains enriched in polar side chains (Arg, Gln, Glu, Ser, Lys) or structure-breaking amino acids (Gly, Pro) (Uversky and Dunker, 2010) . The dynamic formation of MLOs can be regulated by post-translational modifications such as acetylation, SUMOylation, or phosphorylation (Bernardi and Pandolfi, 2007; de la Vega et al., 2011; Saito et al., 2019; Wippich et al., 2013) or by environmental cues such as changes in temperature, pH, or osmolarity (Uversky, 2017) . Interestingly, a small interfering RNA (siRNA) screen identified several kinases as regulators of MLO formation, including the Ser/Thr kinase TBK1 as a regulator of splicing speckles (Berchtold et al., 2018) .
Search related documents:
Co phrase search for related documents- amino acid and cellular signaling: 1, 2, 3, 4, 5, 6, 7, 8, 9
- amino acid and chemical reaction: 1, 2
- amino acid and eukaryotic cell: 1, 2, 3, 4
- amino acid and high concentration: 1, 2, 3, 4, 5, 6, 7
- amino acid and inclusion body: 1, 2, 3
- amino acid and lateral sclerosis: 1, 2, 3
- amino acid and low sequence complexity: 1, 2, 3, 4, 5, 6, 7, 8
- amino acid and low sequence complexity domain: 1, 2
- amino acid and Mö ller: 1
- amino acid and nucleoplasm cytoplasm: 1
- amino acid and phase separation: 1, 2, 3, 4, 5, 6
- amino acid and phase separation form: 1
- amino acid and polar chain: 1
- amino acid and post translational modification: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- amino acid and promyelocytic leukemia: 1, 2
- amino acid and protein rna: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- amino acid and quality control: 1, 2, 3, 4, 5, 6, 7, 8
- amino acid and sequence complexity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- amino acid and signal transduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date